|
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class:
|
|
Trading Symbol
|
|
Name of each exchange on which registered:
|
|
|
|
|
|
Item 1.01.
|
Entry into a Material Definitive Agreement.
|
Item 2.03.
|
Creation of Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
|
Description
|
|
|
|
|
||
|
|
|
104
|
|
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
|
|
IRADIMED CORPORATION
|
|
|
|
|
Date: November 4, 2022
|
|
|
|
By:
|
/s/ John “Jack” Glenn
|
|
Name: John “Jack” Glenn
|
|
|
Title: Chief Financial Officer
|